Oppenheimer Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.57M | Sell |
|
|||||
|
2025
Q1 | $10.5M | Buy |
|
|||||
|
2024
Q4 | $8.27M | Sell |
|
|||||
|
2024
Q3 | $10.9M | Sell |
|
|||||
|
2024
Q2 | $11.4M | Buy |
|
|||||
|
2024
Q1 | $6.02M | Sell |
|
|||||
|
2023
Q4 | $6.7M | Buy |
|
|||||
|
2023
Q3 | $4.88M | Sell |
|
|||||
|
2023
Q2 | $4.96M | Sell |
|
|||||
|
2023
Q1 | $4.51M | Sell |
|
|||||
|
2022
Q4 | $4.4M | Buy |
|
|||||
|
2022
Q3 | $4.37M | Buy |
|
|||||
|
2022
Q2 | $3.79M | Sell |
|
|||||
|
2022
Q1 | $3.72M | Sell |
|
|||||
|
2021
Q4 | $3.23M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $5.76M | Buy |
|
|||||
|
2021
Q1 | $6.08M | Buy |
|
|||||
|
2020
Q4 | $6.59M | Buy |
|
|||||
|
2020
Q3 | $7.21M | Buy |
|
|||||
|
2020
Q2 | $7.59M | Sell |
|
|||||
|
2020
Q1 | $7.45M | Sell |
|
|||||
|
2019
Q4 | $7.42M | Sell |
|
|||||
|
2019
Q3 | $6.28M | Sell |
|
|||||
|
2019
Q2 | $8.89M | Sell |
|
|||||
|
2019
Q1 | $8.98M | Sell |
|
|||||
|
2018
Q4 | $8.72M | Sell |
|
|||||
|
2018
Q3 | $10.4M | Buy |
|
|||||
|
2018
Q2 | $8.83M | Buy |
|
|||||
|
2018
Q1 | $6M | Buy |
|
|||||
|
2017
Q4 | $3.91M | Hold |
|
|||||
|
2017
Q3 | $3.91M | Buy |
|
|||||
|
2017
Q2 | $1.86M | Buy |
|
|||||
|
2017
Q1 | $834K | Buy |
|